Boost for AstraZeneca good news for FTSE

Drugs giant AstraZeneca eased the pressure on the FTSE 100 Index today after its anti-cholesterol drug Crestor received a boost from regulators.

Boost for AstraZeneca good news for FTSE

Drugs giant AstraZeneca eased the pressure on the FTSE 100 Index today after its anti-cholesterol drug Crestor received a boost from regulators.

The heavyweight stock soared after America’s Food and Drug Administration ruled that Crestor – one of the key products in its portfolio – did not have a greater risk of side-effects than similar drugs.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €120 €60

Best value

Monthly €10€5 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited